ISLET-CELL ANTIBODIES ARE ASSOCIATED WITH BETA-CELL FAILURE ALSO IN OBESE ADULT-ONSET DIABETIC-PATIENTS

被引:38
作者
GOTTSATER, A
LANDINOLSSON, M
LERNMARK, A
FERNLUND, P
SUNDKVIST, G
机构
[1] KAROLINSKA INST,KAROLINSKA HOSP,DEPT MED,S-10401 STOCKHOLM,SWEDEN
[2] LUND UNIV,MALMO GEN HOSP,DEPT CLIN CHEM,S-21401 MALMO,SWEDEN
关键词
FASTING C-PEPTIDE; AUTOIMMUNITY; ISLET CELL ANTIBODY;
D O I
10.1007/BF00571956
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To clarify the utility of islet cell antibodies (ICA) to correctly classify and predict insulin treatment in newly diagnosed diabetic subjects, ICA, body mass index (BMI), glycated hemoglobin (HbA(1c)), and fasting plasma C-peptide values were evaluated at and 3 years after diagnosis in 233 new, consecutively diagnosed, adult diabetic patients classified as obese or nonobese (National Diabetes Data Group, NDDG criteria). Among the 233 patients, 31 were nonobese ICA-positive (mean age at diagnosis 43+/-3 years), 55 nonobese ICA-negative (mean age at diagnosis 58+/-2 years), 7 obese ICA-positive (mean age at diagnosis 57+/-5 years), and 139 obese ICA-negative (mean age at diagnosis 58+/-1 years). Fasting C-peptide decreased (P<0.05) in nonobese ICA-positive patients who after 3 years showed lower BMI (22.6+/-0.6 versus 24.5+/-0.4; P<0.05), lower fasting C-peptide (0.14+/-0.06 nmol/l versus 0.71+/-0.07 nmol/l; P<0.001), and higher frequency of insulin treatment [28/31 (90%) versus 6/45 (13%); P<0.001] than nonobese ICA-negative patients. In obese ICA-positive patients, fasting C-peptide also decreased (Delta C-peptide 0.17+/-0.04 nmol/l; P<0.05) after diagnosis, and 3 years after diagnosis, obese ICA-positive patients showed lower BMI (25.7+/-1.2 versus 29.8+/-0.4; P<0.01) and fasting C-peptide (0.08+/-0.04 nmol/l versus 1.06+/-0.05 nmol/l; P<0.001) and higher HbA(1c) values (9.92%+/-0.68% versus 7.39%+/- .21%; P<0.01) and a higher frequency of insulin treatment [7/7 (100%) versus 5/121 (4%); P<0.001] than obese ICA-negative patients. Therefore, ICA detected at diagnosis of diabetes in both obese and nonobese adult patients indicate beta-cell dysfunction, high HbA(1c) levels, and progression to insulin dependency.
引用
收藏
页码:226 / 231
页数:6
相关论文
共 36 条
[1]   REPRODUCIBILITY OF THE GLUCAGON TEST [J].
ARNOLDLARSEN, S ;
MADSBAD, S ;
KUHL, C .
DIABETIC MEDICINE, 1987, 4 (04) :299-303
[2]   IMMUNOLOGY AND DIABETES WORKSHOP - REPORT ON THE 3RD INTERNATIONAL (STAGE-3) WORKSHOP ON THE STANDARDIZATION OF CYTOPLASMIC ISLET CELL ANTIBODIES HELD IN NEW-YORK, NEW-YORK, OCTOBER 1987 [J].
BOITARD, C ;
BONIFACIO, E ;
BOTTAZZO, GF ;
GLEICHMANN, H ;
MOLENAAR, J .
DIABETOLOGIA, 1988, 31 (07) :451-452
[3]   ABNORMAL SENSITIVITY TO GLUCOSE OF HUMAN ISLETS CULTURED IN A HIGH GLUCOSE MEDIUM - PARTIAL REVERSIBILITY AFTER AN ADDITIONAL CULTURE IN A NORMAL GLUCOSE MEDIUM [J].
DAVALLI, AM ;
RICORDI, C ;
SOCCI, C ;
BRAGHI, S ;
BERTUZZI, F ;
FATTOR, B ;
DICARLO, V ;
PONTIROLI, AE ;
POZZA, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (01) :202-208
[4]   HUMAN ISLETS CHRONICALLY EXPOSED INVITRO TO DIFFERENT STIMULI BECOME UNRESPONSIVE TO THE SAME STIMULI GIVEN ACUTELY - EVIDENCE SUPPORTING SPECIFIC DESENSITIZATION RATHER THAN BETA-CELL EXHAUSTION [J].
DAVALLI, AM ;
PONTIROLI, AE ;
SOCCI, C ;
BERTUZZI, F ;
FATTOR, B ;
BRAGHI, S ;
DICARLO, V ;
POZZA, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (04) :790-794
[5]   IMMUNE ABNORMALITIES IN DIABETIC-PATIENTS NOT REQUIRING INSULIN AT DIAGNOSIS [J].
DIMARIO, U ;
IRVINE, WJ ;
BORSEY, DQ ;
KYNER, JL ;
WESTON, J ;
GALFO, C .
DIABETOLOGIA, 1983, 25 (05) :392-395
[6]   CLINICAL AND METABOLIC CHARACTERISTICS OF TYPE-1 AND TYPE-2 DIABETES - AN EPIDEMIOLOGIC-STUDY FROM THE NARPES COMMUNITY IN WESTERN FINLAND [J].
ERIKSSON, J ;
FORSEN, B ;
HAGGBLOM, M ;
TEPPO, AM ;
GROOP, L .
DIABETIC MEDICINE, 1992, 9 (07) :654-660
[7]   THE PLASMA C-PEPTIDE AND INSULIN RESPONSES TO STIMULATION WITH INTRAVENOUS GLUCAGON AND A MIXED MEAL IN WELL-CONTROLLED TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS - DEPENDENCY ON ACUTELY ESTABLISHED HYPERGLYCEMIA [J].
GJESSING, HJ ;
REINHOLDT, B ;
PEDERSEN, O .
DIABETOLOGIA, 1989, 32 (12) :858-863
[8]   CORRELATION OF ISLET CELL ANTIBODIES AND HLA-DR PHENOTYPES WITH DIABETES-MELLITUS IN ADULTS [J].
GLEICHMANN, H ;
ZORCHER, B ;
GREULICH, B ;
GRIES, FA ;
HENRICHS, HR ;
BERTRAMS, J ;
KOLB, H .
DIABETOLOGIA, 1984, 27 :90-92
[9]   BETA-CELL FUNCTION IN RELATION TO ISLET-CELL ANTIBODIES DURING THE 1ST 3 YR AFTER CLINICAL-DIAGNOSIS OF DIABETES IN TYPE-II DIABETIC-PATIENTS [J].
GOTTSATER, A ;
LANDINOLSSON, M ;
FERNLUND, P ;
LERNMARK, A ;
SUNDKVIST, G .
DIABETES CARE, 1993, 16 (06) :902-910
[10]   PANCREATIC BETA-CELL FUNCTION EVALUATED BY INTRAVENOUS GLUCOSE AND GLUCAGON STIMULATION - A COMPARISON BETWEEN INSULIN AND C-PEPTIDE TO MEASURE INSULIN-SECRETION [J].
GOTTSATER, A ;
LANDINOLSSON, M ;
FERNLUND, P ;
GULLBERG, B ;
LERNMARK, A ;
SUNDKVIST, G .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1992, 52 (07) :631-639